These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 25146864

  • 1. The current state of ototoxicity monitoring in New Zealand.
    Steffens L, Venter K, O'Beirne GA, Kelly-Campbell R, Gibbs D, Bird P.
    N Z Med J; 2014 Jul 18; 127(1398):84-97. PubMed ID: 25146864
    [Abstract] [Full Text] [Related]

  • 2. Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program.
    Paken J, Govender CD, Sewram V.
    BMC Womens Health; 2017 Dec 11; 17(1):129. PubMed ID: 29228931
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of hearing in children with solid tumors treated by chemotherapy].
    Gryczyńska D, Rychwalska M, Pekacka K, Krawczyński M, Bodalski J.
    Otolaryngol Pol; 2001 Dec 11; 55(2):179-83. PubMed ID: 11494735
    [Abstract] [Full Text] [Related]

  • 4. Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology.
    Garinis AC, Cornell A, Allada G, Fennelly KP, Maggiore RJ, Konrad-Martin D.
    Int J Audiol; 2018 Sep 11; 57(sup4):S19-S24. PubMed ID: 28978238
    [Abstract] [Full Text] [Related]

  • 5. Practice of Monitoring Cisplatin-Induced Ototoxicity by Audiology, ENT, and Oncology Specialists: A Survey-Based Study in a Single Italian Medical Center.
    Gambacorta V, Orzan E, Faralli M, Gullà M, Lapenna R, Baietta I, De Angelis V, Ricci G.
    Audiol Res; 2023 Oct 18; 13(5):779-790. PubMed ID: 37887850
    [Abstract] [Full Text] [Related]

  • 6. Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa.
    Paken J, Govender CD, Pillay M, Ayele BT, Sewram V.
    BMC Cancer; 2021 Jul 16; 21(1):822. PubMed ID: 34271863
    [Abstract] [Full Text] [Related]

  • 7. What Are the Current Audiological Practices for Ototoxicity Assessment and Management in the South African Healthcare Context?
    Khoza-Shangase K, Masondo N.
    Int J Environ Res Public Health; 2020 Apr 10; 17(7):. PubMed ID: 32290287
    [Abstract] [Full Text] [Related]

  • 8. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ, Kraus DH, Budnick AS, Bayer LA, Finlay JL.
    Med Pediatr Oncol; 1996 Feb 10; 26(2):95-100. PubMed ID: 8531860
    [Abstract] [Full Text] [Related]

  • 9. Perspectives and practices of ototoxicity monitoring.
    Paken J, Govender CD, Pillay M, Sewram V.
    S Afr J Commun Disord; 2020 May 19; 67(1):e1-e10. PubMed ID: 32501032
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin ototoxicity in children: implications for primary care providers.
    Helt-Cameron J, Allen PJ.
    Pediatr Nurs; 2009 May 19; 35(2):121-7. PubMed ID: 19472677
    [Abstract] [Full Text] [Related]

  • 11. Insight into the current practice of ototoxicity monitoring during cisplatin therapy.
    Santucci NM, Garber B, Ivory R, Kuhn MA, Stephen M, Aizenberg D.
    J Otolaryngol Head Neck Surg; 2021 Mar 25; 50(1):19. PubMed ID: 33766142
    [Abstract] [Full Text] [Related]

  • 12. Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
    Bertolini P, Lassalle M, Mercier G, Raquin MA, Izzi G, Corradini N, Hartmann O.
    J Pediatr Hematol Oncol; 2004 Oct 25; 26(10):649-55. PubMed ID: 15454836
    [Abstract] [Full Text] [Related]

  • 13. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
    Abujamra AL, Escosteguy JR, Dall'Igna C, Manica D, Cigana LF, Coradini P, Brunetto A, Gregianin LJ.
    Pediatr Blood Cancer; 2013 Mar 25; 60(3):474-8. PubMed ID: 22744939
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical study on the ototoxicity of cisplatin with distortion products].
    Orts Alborch M, García Callejo J, Morant Ventura A, Ferrer Baixauli F, Esparcia Navarro M, Marco Algarra J.
    Acta Otorrinolaringol Esp; 2000 Mar 25; 51(6):469-77. PubMed ID: 11142781
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cisplatinum ototoxicity in children, long-term follow up.
    Al-Khatib T, Cohen N, Carret AS, Daniel S.
    Int J Pediatr Otorhinolaryngol; 2010 Aug 25; 74(8):913-9. PubMed ID: 20846503
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin-associated ototoxicity: perspectives from a single institution cervical cancer cohort and implications for developing a locally responsive monitoring programme in a public healthcare setting.
    Paken J, Govender CD, Pillay M, Sewram V.
    BMC Health Serv Res; 2022 Jun 18; 22(1):791. PubMed ID: 35717191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.